Pages that link to "Q29615481"
Jump to navigation
Jump to search
The following pages link to Cancer nanotechnology: opportunities and challenges (Q29615481):
Displaying 50 items.
- The effect of surface nanometre-scale morphology on protein adsorption (Q21136246) (← links)
- Killing cancer cells by targeted drug-carrying phage nanomedicines (Q21256651) (← links)
- Noble metal nanoparticles applications in cancer (Q21284977) (← links)
- Handling worker and third-party exposures to nanotherapeutics during clinical trials (Q23913310) (← links)
- Micro-NMR for rapid molecular analysis of human tumor samples (Q24603587) (← links)
- Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer (Q24614491) (← links)
- Drug delivery and nanoparticles:applications and hazards (Q24655744) (← links)
- Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer (Q24657308) (← links)
- Canine parvovirus-like particles, a novel nanomaterial for tumor targeting (Q25256822) (← links)
- Aerosol droplet delivery of mesoporous silica nanoparticles: a strategy for respiratory-based therapeutics (Q26343130) (← links)
- Recent Developments of Liposomes as Nanocarriers for Theranostic Applications (Q26744835) (← links)
- Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer (Q26767044) (← links)
- Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases (Q26772210) (← links)
- Diagnosis of prostate cancer via nanotechnological approach (Q26777322) (← links)
- Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies (Q26783705) (← links)
- Adenosine-associated delivery systems (Q26785351) (← links)
- Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer (Q26828849) (← links)
- Hybrid nanoparticles for detection and treatment of cancer (Q26849404) (← links)
- Safe clinical use of carbon nanotubes as innovative biomaterials (Q26851720) (← links)
- Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy (Q26858849) (← links)
- Therapeutic radionuclides in nuclear medicine: current and future prospects (Q26861998) (← links)
- Nanoparticle delivery enhancement with acoustically activated microbubbles (Q26866082) (← links)
- Enzyme-responsive nanomaterials for controlled drug delivery (Q26992127) (← links)
- The physiology of cardiovascular disease and innovative liposomal platforms for therapy (Q27002949) (← links)
- An overview of clinical and commercial impact of drug delivery systems (Q27007143) (← links)
- Targeted nanotechnology for cancer imaging (Q27010317) (← links)
- Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market (Q27015050) (← links)
- Targeted therapy using nanotechnology: focus on cancer (Q27023361) (← links)
- A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR Effect (Q27300754) (← links)
- Adjusting the balance between effective loading and vector migration of macrophage vehicles to deliver nanoparticles (Q27304963) (← links)
- Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method (Q27333732) (← links)
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery (Q28085280) (← links)
- Current investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitations (Q28087733) (← links)
- Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment (Q28243455) (← links)
- Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer (Q28291499) (← links)
- Nanotechnology and Mri Contrast Enhancement (Q28307795) (← links)
- Single-walled carbon nanotube interactions with HeLa cells (Q28382896) (← links)
- Nanomedicine: promises and challenges for the future of public health (Q28384103) (← links)
- Carbon nanotubes: an emerging drug carrier for targeting cancer cells (Q28385865) (← links)
- Nanomaterials and autophagy: new insights in cancer treatment (Q28386642) (← links)
- Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats (Q28387832) (← links)
- Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dots (Q28388580) (← links)
- Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine (Q28391849) (← links)
- Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models (Q28392542) (← links)
- Nano polymeric carrier fabrication technologies for advanced antitumor therapy (Q28393168) (← links)
- The application of carbon nanotubes in target drug delivery systems for cancer therapies (Q28393485) (← links)
- Nanoparticles for imaging and treating brain cancer (Q28394053) (← links)
- Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns (Q28396462) (← links)
- Analysis of the influence of cell heterogeneity on nanoparticle dose response (Q28396936) (← links)
- Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting (Q28475666) (← links)